Diabetes, metformin use and survival in esophageal cancer: a population-based cohort study.

Diabetes was associated with an increased all-cause mortality while metformin use was associated with decreased all-cause mortality among esophageal cancer patients. More research is needed to determine if metformin affects survival in esophageal cancer.